Silence Therapeutics (SLNCF) Current Leases (2019 - 2025)
Historic Current Leases for Silence Therapeutics (SLNCF) over the last 7 years, with Q3 2025 value amounting to $85000.0.
- Silence Therapeutics' Current Leases rose 14706.46% to $85000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $85000.0, marking a year-over-year increase of 14706.46%. This contributed to the annual value of $117000.0 for FY2024, which is 4868.42% down from last year.
- As of Q3 2025, Silence Therapeutics' Current Leases stood at $85000.0, which was up 14706.46% from $60000.0 recorded in Q1 2025.
- Silence Therapeutics' 5-year Current Leases high stood at $523126.0 for Q4 2022, and its period low was -$588095.6 during Q3 2022.
- Moreover, its 5-year median value for Current Leases was -$180602.7 (2024), whereas its average is -$110065.2.
- Per our database at Business Quant, Silence Therapeutics' Current Leases plummeted by 124328.85% in 2021 and then soared by 18326.47% in 2022.
- Over the past 5 years, Silence Therapeutics' Current Leases (Quarter) stood at $184677.4 in 2021, then skyrocketed by 183.26% to $523126.0 in 2022, then tumbled by 142.47% to -$222166.2 in 2023, then skyrocketed by 152.66% to $117000.0 in 2024, then fell by 27.35% to $85000.0 in 2025.
- Its last three reported values are $85000.0 in Q3 2025, $60000.0 for Q1 2025, and $117000.0 during Q4 2024.